Carmell Therapeutics Corporation (CTCX) NASDAQ
0.20
+0.0027(+1.39%)
Currency In USD
- General
- Statistics
- Historical Data
- Profile
- Financials
0.20
+0.0027(+1.39%)
Currency In USD
| Market Cap | 167,258.17 |
| Enterprise Value | -229,543 |
| P/E Ratio | -0.06 |
| PEG Ratio | 0 |
| Price/Sales Ratio | 0.19 |
| Price/Book Ratio | -0.08 |
| Enterprise/Revenue | 0.09 |
| Enterprise/EBITDA | -0.02 |
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | December 31, 2025 |
| Profit Margin | -3.61 |
| Operating Margin | -3.72 |
| Return On Assets | -2.92 |
| Return On Equity | 1.59 |
| Revenue | 1.91M |
| Revenue/Share | 1.11 |
| Gross Profit | 1.09M |
| EBITDA | -6.81M |
| Net Income | -6.91M |
| Diluted EPS | -4.83 |
| Total Cash | 706,740 |
| Total Cash/Share | 0.41 |
| Total Debt | 309,938 |
| Total Debt/Equity | -0.09 |
| Current Ratio | 0.25 |
| Book Value Per Share | -3.41 |
| 52-Week Change | -92.69 |
| 52-Week High | 3 |
| 52-Week Low | 0.17 |
| Moving Average 50 Days | 0.35 |
| Moving Average 200 Days | 0.63 |
| Average Volume | 8.24M |
| Shares Outstanding | 30.12M |
| % Held by Institutions | N/A |
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | N/A |
| Last Split Date | N/A |